Quarterly report pursuant to Section 13 or 15(d)

INVESTMENTS IN UNCONSOLIDATED JOINT VENTURES - Schedule of Equity Method Investment, Summarized Financial Information, Income Statement (Details)

v3.23.2
INVESTMENTS IN UNCONSOLIDATED JOINT VENTURES - Schedule of Equity Method Investment, Summarized Financial Information, Income Statement (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Schedule of Equity Method Investments [Line Items]        
Total revenues $ 68,729 $ 53,813 $ 135,688 $ 103,314
Operating and other expenses (14,044) (13,100) (26,307) (25,964)
Depreciation and amortization (23,684) (21,015) (47,331) (39,456)
Interest expense (21,692) (14,741) (43,706) (26,348)
Net (loss) income (30,135) 34,650 (46,365) 30,123
Equity Method Investment, Nonconsolidated Investee or Group of Investees        
Schedule of Equity Method Investments [Line Items]        
Total revenues 25,945 41,345 47,770 77,472
Operating and other expenses (8,698) (22,317) (17,142) (47,816)
Depreciation and amortization (5,572) (6,381) (11,137) (12,941)
Interest expense (7,762) (7,051) (15,475) (13,827)
Net (loss) income $ 3,913 $ 5,596 $ 4,016 $ 2,888